BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18952690)

  • 1. Impact of reporting rules of biopsy Gleason score for prostate cancer.
    Kuroiwa K; Uchino H; Yokomizo A; Naito S
    J Clin Pathol; 2009 Mar; 62(3):260-3. PubMed ID: 18952690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice.
    Zareba P; Zhang J; Yilmaz A; Trpkov K
    Histopathology; 2009 Oct; 55(4):384-91. PubMed ID: 19817888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?
    Choo R; Danjoux C; Morton G; Szumacher E; Sugar L; Gardner S; Kim M; Choo CM; Klotz L
    Prostate; 2007 Nov; 67(15):1614-20. PubMed ID: 17823923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upgrading the Gleason score in extended prostate biopsy: implications for treatment choice.
    Moreira Leite KR; Camara-Lopes LH; Dall'Oglio MF; Cury J; Antunes AA; Sañudo A; Srougi M
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):353-6. PubMed ID: 18774658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end point.
    Delahunt B; Lamb DS; Srigley JR; Murray JD; Wilcox C; Samaratunga H; Atkinson C; Spry NA; Joseph D; Denham JW
    Pathology; 2010 Jun; 42(4):339-43. PubMed ID: 20438406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.
    Rajinikanth A; Manoharan M; Soloway CT; Civantos FJ; Soloway MS
    Urology; 2008 Jul; 72(1):177-82. PubMed ID: 18279938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.
    Burdick MJ; Reddy CA; Ulchaker J; Angermeier K; Altman A; Chehade N; Mahadevan A; Kupelian PA; Klein EA; Ciezki JP
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1439-45. PubMed ID: 18963536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of Gleason grading among 337 European pathologists.
    Egevad L; Ahmad AS; Algaba F; Berney DM; Boccon-Gibod L; Compérat E; Evans AJ; Griffiths D; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Moss S; Oliveira P; Vainer B; Varma M; Camparo P
    Histopathology; 2013 Jan; 62(2):247-56. PubMed ID: 23240715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
    Kvåle R; Møller B; Wahlqvist R; Fosså SD; Berner A; Busch C; Kyrdalen AE; Svindland A; Viset T; Halvorsen OJ
    BJU Int; 2009 Jun; 103(12):1647-54. PubMed ID: 19154461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current practice of Gleason grading among genitourinary pathologists.
    Egevad L; Allsbrook WC; Epstein JI
    Hum Pathol; 2005 Jan; 36(1):5-9. PubMed ID: 15712175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
    Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
    BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saturation biopsy improves preoperative Gleason scoring of prostate cancer.
    Kahl P; Wolf S; Adam A; Heukamp LC; Ellinger J; Vorreuther R; Solleder G; Buettner R
    Pathol Res Pract; 2009; 205(4):259-64. PubMed ID: 19106019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy.
    Ozden C; Oztekin CV; Ugurlu O; Gokkaya S; Yaris M; Memis A
    Urol Int; 2009; 83(2):146-50. PubMed ID: 19752607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?
    Kunju LP; Daignault S; Wei JT; Shah RB
    Hum Pathol; 2009 Apr; 40(4):558-64. PubMed ID: 19144380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate.
    Nguyen PL; Schultz D; Renshaw AA; Vollmer RT; Welch WR; Cote K; D'Amico AV
    Urol Oncol; 2004; 22(4):295-9. PubMed ID: 15283886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.